Amphera Announces a Positive Opinion of the European Medicines Agency on the Granting of Orphan Medicinal Product Designation for MesoPher in Pancreatic Cancer

0
77
Amphera B.V. announced that the European Medicines Agency Committee for Orphan Medicinal Products recommended the granting of orphan medicinal product designation for MesoPher in pancreatic cancer.
[Amphera B.V.]
Press Release